PSNL
Personalis, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$16.40
+1.05%0
Insider buys (3m)
5
Insider sells (3m)
-$5.1M
Net value (3m)
+60.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 15, 2026 | Chen Richard · officer: President and CMO | M-Exempt | 100,000 | $2.44 |
| Jul 15, 2026 | Chen Richard · officer: President and CMO | Sale | 100,000 | $15 |
| Jul 9, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | M-Exempt | 66,667 | $1.61 |
| Jul 9, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | Sale | 100,000 | $15 |
| Jul 9, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | M-Exempt | 100,000 | $1.61 |
| Jul 9, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | M-Exempt | 33,333 | $1.61 |
| Jun 29, 2026 | Tachibana Aaron · officer: CFO AND COO | M-Exempt | 4,982 | $5.32 |
| Jun 29, 2026 | Tachibana Aaron · officer: CFO AND COO | Sale | 4,982 | $14 |
| Jun 26, 2026 | Tachibana Aaron · officer: CFO AND COO | M-Exempt | 28,832 | $9.16 |
| Jun 26, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | M-Exempt | 100,000 | $1.61 |
| Jun 26, 2026 | Tachibana Aaron · officer: CFO AND COO | Sale | 51,251 | $13 |
| Jun 26, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | Sale | 100,000 | $13 |
| Jun 26, 2026 | Tachibana Aaron · officer: CFO AND COO | M-Exempt | 22,419 | $5.32 |
| Jun 11, 2026 | EASTHAM KARIN · director | A-Award | 6,250 | $0.00 |
| Jun 5, 2026 | Tachibana Aaron · officer: CFO AND COO | Sale | 40,000 | $12 |
| Jun 5, 2026 | Tachibana Aaron · officer: CFO AND COO | M-Exempt | 40,000 | $9.16 |
| May 29, 2026 | Tachibana Aaron · officer: CFO AND COO | M-Exempt | 38,799 | $9.16 |
| May 29, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | M-Exempt | 80,091 | $1.61 |
| May 29, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | M-Exempt | 19,909 | $1.61 |
| May 29, 2026 | Tachibana Aaron · officer: CFO AND COO | Sale | 38,799 | $12 |
| May 29, 2026 | Hall Christopher M · director, officer: Chief Executive Officer | Sale | 80,091 | $11 |
| May 14, 2026 | Bloom Olivia Kyusuk · director | A-Award | 37,500 | $6.04 |
| May 14, 2026 | EASTHAM KARIN · director | A-Award | 6,250 | $0.00 |
| May 14, 2026 | EASTHAM KARIN · director | A-Award | 37,500 | $6.04 |
| May 14, 2026 | BOWMAN A BLAINE · director | A-Award | 6,250 | $0.00 |
| May 14, 2026 | BOWMAN A BLAINE · director | A-Award | 37,500 | $6.04 |
| May 14, 2026 | WIDDER KENNETH J · director | A-Award | 6,250 | $0.00 |
| May 14, 2026 | WIDDER KENNETH J · director | A-Award | 37,500 | $6.04 |
| May 14, 2026 | Shoff Lonnie · director | A-Award | 6,250 | $0.00 |
| May 14, 2026 | Shoff Lonnie · director | A-Award | 37,500 | $6.04 |
Institutional positioning
13F filings over the trailing two quarters
New 78Increased 117Reduced 73Sold out 22
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MERCK & CO., INC. | Unchanged | 14,044,943 | May 13, 2026 |
| Merck & Co., Inc. | Unchanged | 14,044,943 | Aug 7, 2026 |
| ARK Investment Management LLC | Increased | 8,271,339 | Aug 14, 2026 |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | Unchanged | 8,160,734 | May 15, 2026 |
| ARK INVESTMENT MANAGEMENT LLC | Increased | 7,944,112 | May 12, 2026 |
| AMERIPRISE FINANCIAL INC | Increased | 7,592,807 | Jul 17, 2026 |
| BlackRock, Inc. | Increased | 7,082,491 | Aug 7, 2026 |
| Lightspeed Management Company, L.L.C. | Reduced | 6,101,850 | Aug 14, 2026 |
| AMERIPRISE FINANCIAL INC | Reduced | 6,086,315 | Aug 14, 2026 |
| BLACKROCK, INC. | Increased | 5,389,885 | May 13, 2026 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | Reduced | 4,758,091 | May 15, 2026 |
| Deep Track Capital, LP | Increased | 4,000,000 | Aug 14, 2026 |
| Aberdeen Group plc | Increased | 3,747,290 | Jul 31, 2026 |
| ABRDN PLC | Increased | 3,488,308 | Apr 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 3,010,150 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 15, 2026